These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39585303)
1. Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767. Ramachandran P; Brice M; Sutherland EF; Hoy AM; Papachristoforou E; Jia L; Turner F; Kendall TJ; Marwick JA; Carragher NO; Oro D; Feigh M; Leeming DJ; Nielsen MJ; Karsdal MA; Hartmann N; Erickson M; Adorini L; Roth JD; Fallowfield JA Hepatol Commun; 2024 Dec; 8(12):. PubMed ID: 39585303 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
3. Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse model. Taylor R; Basaly V; Kong B; Yang I; Brinker AM; Capece G; Bhattacharya A; Henry ZR; Otersen K; Yang Z; Meadows V; Mera S; Joseph LB; Zhou P; Aleksunes LM; Roepke T; Buckley B; Guo GL Toxicol Sci; 2024 Dec; 202(2):179-195. PubMed ID: 39302723 [TBL] [Abstract][Full Text] [Related]
4. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
5. Dodecanedioic acid prevents and reverses metabolic-associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet-induced obesity. Angelini G; Russo S; Carli F; Infelise P; Panunzi S; Bertuzzi A; Caristo ME; Lembo E; Calce R; Bornstein SR; Gastaldelli A; Mingrone G FASEB J; 2024 Nov; 38(22):e70202. PubMed ID: 39600104 [TBL] [Abstract][Full Text] [Related]
6. Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results. Wing K; Williamson E; Carpenter JR; Wise L; Schneeweiss S; Smeeth L; Quint JK; Douglas I Health Technol Assess; 2021 Aug; 25(51):1-70. PubMed ID: 34463610 [TBL] [Abstract][Full Text] [Related]
10. What Are the Functional, Radiographic, and Survivorship Outcomes of a Modified Cup-cage Technique for Pelvic Discontinuity? Mu W; Xu B; Wahafu T; Wang F; Guo W; Zou C; Cao L Clin Orthop Relat Res; 2024 Dec; 482(12):2149-2160. PubMed ID: 38991223 [TBL] [Abstract][Full Text] [Related]
11. Diabetes as a risk factor for tuberculosis disease. Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K Cochrane Database Syst Rev; 2024 Aug; 8(8):CD016013. PubMed ID: 39177079 [TBL] [Abstract][Full Text] [Related]
12. Catalpol ameliorates liver fibrosis via inhibiting aerobic glycolysis by EphA2/FAK/Src signaling pathway. Zhang Q; Ran T; Li S; Han L; Chen S; Lin G; Wu H; Wu H; Feng S; Chen J; Zhang Q; Zhao X Phytomedicine; 2024 Dec; 135():156047. PubMed ID: 39321687 [TBL] [Abstract][Full Text] [Related]
13. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
14. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
15. Accuracy of the Wound Healing Questionnaire in the diagnosis of surgical-site infection after abdominal surgery in low- and middle-income countries. NIHR Global Health Research Unit on Global Surgery Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38747515 [TBL] [Abstract][Full Text] [Related]
16. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults. Love AMA; Edwards C; Cai RY; Gibbs V Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059 [TBL] [Abstract][Full Text] [Related]
17. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis. Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741 [TBL] [Abstract][Full Text] [Related]
18. A Blog-Based Study of Autistic Adults' Experiences of Aloneness and Connection and the Interplay with Well-Being: Corpus-Based and Thematic Analyses. Petty S; Allen S; Pickup H; Woodier B Autism Adulthood; 2023 Dec; 5(4):437-449. PubMed ID: 38116056 [TBL] [Abstract][Full Text] [Related]
19. Study on the molecular mechanisms of rifaximin in the treatment of non‑alcoholic steatohepatitis based on the Wan YP; Li S; Li D; Huang XM; Wu JH; Jian J Mol Med Rep; 2025 Feb; 31(2):. PubMed ID: 39611479 [TBL] [Abstract][Full Text] [Related]